|
Volumn 42, Issue 2-3, 2012, Pages 1077-1082
|
Concluding remarks
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACROLEIN;
ANTHRACENE;
ANTIZYME;
BIGUANIDE DERIVATIVE;
DOCETAXEL;
EFLORNITHINE;
GUANIDINE DERIVATIVE;
HYPUSINE;
N1,N12 DIACETYLSPERMINE;
ORNITHINE DECARBOXYLASE;
POLYAMINE DERIVATIVE;
PROSTATE SPECIFIC ANTIGEN;
PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;
REACTIVE OXYGEN METABOLITE;
SPERMINE;
SPERMINE DERIVATIVE;
THIOUREA;
UNCLASSIFIED DRUG;
UREA;
ANTIMALARIAL ACTIVITY;
CANCER GROWTH;
CANCER INHIBITION;
CANCER RESEARCH;
CHRONIC MYELOID LEUKEMIA;
COLORECTAL CANCER;
CONFERENCE PAPER;
CYTOTOXICITY;
DIET SUPPLEMENTATION;
DRUG SYNTHESIS;
DRUG TUMOR LEVEL;
ENZYME ACTIVITY;
HUMAN;
MALIGNANT NEOPLASTIC DISEASE;
MEDICAL RESEARCH;
NONHUMAN;
OXIDATIVE STRESS;
PLASMODIUM BERGHEI;
PLASMODIUM FALCIPARUM;
PRIORITY JOURNAL;
PROSTATE CANCER;
PUBLICATION;
SKIN CANCER;
|
EID: 84862688530
PISSN: 09394451
EISSN: 14382199
Source Type: Journal
DOI: 10.1007/s00726-011-1022-z Document Type: Conference Paper |
Times cited : (1)
|
References (0)
|